From AI to Musk’s brain chips, the FDA’s device unit faces rapid change
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
pharmaphorum1d
First human subject receives a Neuralink brain implant
Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.
The Daily Star27d
neuralink brain chip
Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation ...
Reuters7d
Neuralink Corp.
Disruptedcategory Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant September 18, 2024 Healthcare & Pharmaceuticalscategory Musk's Neuralink says second trial implant ...
CBS News7d
FDA to pull common but ineffective cold medicine from market
The FDA's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral phenylephrine, citing concerns with the initial data used ...
Fox News7d
RFK Jr. wants to clear out 'entire departments' in the FDA: 'They have to go'
Robert F. Kennedy Jr. suggested the second Trump administration could eliminate entire departments within the Food and Drug Administration (FDA) for "corruption." The former independent ...
The Hill21d
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
USA Today22d
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
Per the FDA, nitrosamine impurities "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time." However, it added, "a person taking a ...
Yahoo23d
FDA issues recall for antidepressant drug
Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous, according to the FDA. The agency labeled the recall as a Class ...
STAT13d
Novo asks FDA to bar compounders from making Ozempic copies
Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years. But Novo argued that semaglutide ...
MLive23d
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Earlier this month the FDA announced a recall of 7,107 bottles of Duloxetine Delayed-Release Capsules because of an elevated level of a cancer-causing chemical known as N-nitroso-duloxetine.
U.S. News & World Report1mon
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making ...